| P50 | author | Martin Malmsten | Q58780071 |
| | Artur Schmidtchen | Q88461456 |
| | Martina Kalle | Q114138745 |
| P2093 | author name string | Matthias Mörgelin | |
| | Douglas M Tollefsen | |
| | Praveen Papareddy | |
| | Gopinath Kasetty | |
| P2860 | cites work | Histidine-rich glycoprotein protects from systemic Candida infection | Q24313429 |
| | Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism | Q24534965 |
| | Heparin cofactor II inhibits arterial thrombosis after endothelial injury | Q24551168 |
| | Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3 | Q28117302 |
| | Antimicrobial peptides of multicellular organisms | Q28131811 |
| | Pigment epithelium-derived factor: a potent inhibitor of angiogenesis | Q28139159 |
| | Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation | Q28205180 |
| | Protein C inhibitor--a novel antimicrobial agent | Q28268083 |
| | Interaction of heparin cofactor II with neutrophil elastase and cathepsin G | Q28280127 |
| | Proteolysis of human thrombin generates novel host defense peptides | Q29871443 |
| | Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes | Q33583259 |
| | C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules | Q34107512 |
| | Hormone binding globulins undergo serpin conformational change in inflammation | Q34167746 |
| | Genetic control of blood pressure and the angiotensinogen locus | Q34498129 |
| | Shape-shifting serpins--advantages of a mobile mechanism | Q34544636 |
| | The contact system--a novel branch of innate immunity generating antibacterial peptides | Q35191114 |
| | Serpins in thrombosis, hemostasis and fibrinolysis | Q36884340 |
| | The antipathogen activities of eosinophil cationic protein | Q37233059 |
| | Vascular Dermatan Sulfate and Heparin Cofactor II | Q37784316 |
| | Coagulation systems of invertebrates and vertebrates and their roles in innate immunity: the same side of two coins? | Q37807232 |
| | Lactoferrin a multiple bioactive protein: an overview. | Q37897330 |
| | Antimicrobial RNases in cutaneous defense. | Q37983362 |
| | Cationic host defence peptides: multifaceted role in immune modulation and inflammation. | Q38022156 |
| | Maspin: molecular mechanisms and therapeutic implications | Q38023237 |
| | A comparison of three heparin-binding serine proteinase inhibitors | Q38328907 |
| | Role of the proposed serpin-enzyme complex receptor recognition site in binding and internalization of thrombin-heparin cofactor II complexes by hepatocytes | Q41176529 |
| | Innate immunity and coagulation. | Q42856952 |
| | Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure | Q43911431 |
| | Ultrasensitive assays for endogenous antimicrobial polypeptides | Q45416239 |
| | Domain 5 of high molecular weight kininogen is antibacterial | Q46642869 |
| | Heparin binding protein is increased in chronic leg ulcer fluid and released from granulocytes by secreted products of Pseudomonas aeruginosa. | Q51642205 |
| | C1 inhibitor, a multi-functional serine protease inhibitor | Q56772868 |
| | Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin–HCII complex | Q57649373 |
| | Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia | Q67564079 |
| | Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity | Q69597083 |
| | Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis | Q73013486 |
| | Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers | Q74211300 |
| | [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role] | Q77814040 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | proteolysis | Q33123 |
| | heparin | Q190016 |
| P304 | page(s) | 6303-6310 | |
| P577 | publication date | 2013-05-08 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Proteolytic activation transforms heparin cofactor II into a host defense molecule | |
| P478 | volume | 190 | |